Use of combination of satins as antagonists of SPARC in stomach cancer: an in silico study

Use of combination of satins as antagonists of SPARC in stomach cancer: an in silico study

This project report is submitted in partial fulfilment of the requirements for the degree of Bachelor of Pharmacy, 2019.

Dades bibliogràfiques
Autor principal:	Rashed, Sadman Sakib Bin
Altres autors:	Kabir, Eva Rahman
Format:	Project report
Idioma:	English
Publicat:	Brac University 2019
Matèries:	SPARC Statins Stomach / Gastric cancer Drug repurposing Molecular docking Protein-ligand interactions Stomach > Cancer.
Accés en línia:	http://hdl.handle.net/10361/12387

Ítems similars

Role of statins as antagonists of SPARC in gastric cancer
per: Shahmat, Rad
Publicat: (2019)

Target specificity of different phytochemicals in preventing the binding of OxLDL To LOX-1: An in silico approach
per: Alam, Ratul, et al.
Publicat: (2023)

Molecular docking of Fluvastatin and Teneligliptin targeting AT1R in hypertension
per: Jahan, Esrat
Publicat: (2020)

Inhibition of Fibroblast Activation Protein alpha (FAP-α) in Colorectal Cancer
per: Tabassum, Azwada
Publicat: (2021)

Understanding Helicobacter pylori Infection Prevalence and Associated Factors in slum and swampy areas of Narayanganj, Bangladesh: Findings from Medical Camps
per: Jarin, Ismath, et al.
Publicat: (2024)

Role of toll-like receptors in cancer immunotherapy– a review
per: Khan, Rezia Nowrin
Publicat: (2021)

Targeting DHFR in breast cancer: exploring expression patterns and identifying potential inhibitors through docking studies
per: Araf, Faiaz Fahim
Publicat: (2024)

A comprehensive review on drug repurposing in cancer treatment
per: Sarkar, Onusree
Publicat: (2024)

A comprehensive bioinformatics analysis of BRAF in cancer
per: Ahmed, Bagdad
Publicat: (2021)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
per: Chakraborty, Anuradha
Publicat: (2024)

Molecules associated with the development of lung cancer
per: Rahman, Adree, et al.
Publicat: (2023)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
per: Das, Reshita
Publicat: (2024)

Molecular biology of cancer : mechanisms, targets, and therapeutics /
per: Pecorino, Lauren
Publicat: (2012)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
per: Flora, Sanzida Alam
Publicat: (2024)

A review on the potential of repurposing of metformin for colon cancer and breast cancer
per: Oishy, Jannatun Noor
Publicat: (2024)

Heat shock protein: potential approach for chemotherapy
per: Sykut, Md. Rezaul Hoque
Publicat: (2022)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
per: Abir, Shifaty Nur
Publicat: (2024)

Statistics and informatics in molecular cancer research

A computational approach to find alternative drugs for managing depression
per: Mubashira, Musharrat Shaheed
Publicat: (2022)

A review on principles of molecular docking and its application in drug discovery
per: Sharif Ezzaz, Ahamed
Publicat: (2024)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
per: Hasan, Amit
Publicat: (2024)

Cancer risk factors: a critical review
per: Tabassum, Tahsina
Publicat: (2017)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
per: Nawar, Anika
Publicat: (2019)

A comprehensive in silico investigation into the pathogenic SNPs in RTEL1 gene and their biological consequences
per: Tanshee, Rifah Rownak
Publicat: (2023)

Anti-inflammatory effect of Statins in reducing the exacerbation and mortality rates of COPD patients: a review study
per: Shomi, Iffat Ara
Publicat: (2019)

Targeting BRAFV600E in the treatment of CRC
per: Roja, Mashwiyat Samrin
Publicat: (2024)

Trend in approval of targeted biologics in the last two decades
per: Siddika, Khadiza
Publicat: (2024)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
per: Pial, Sazia Afrin
Publicat: (2018)

A review on potential anticancer properties of antidiabetic drugs: metformin and sulfonylureas
per: Hossain, Tamara
Publicat: (2024)

Epigenetic therapy in cancer
per: Abid, Md. Shadman Ridwan
Publicat: (2021)

Current practice and approaches of immunotherapy in Cancer treatment
per: Khondokar, Faiza
Publicat: (2022)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
per: Zangmo, Thinley
Publicat: (2024)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
per: Rahman, Sanjida
Publicat: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
per: Jahan, Nusrat
Publicat: (2024)

Biosimilar in lymphoma treatment
per: Tanisha, Mehrin Haque
Publicat: (2021)

Current perspectives on cancer prevention strategies: implications for Bangladesh
per: Afrin, Sajia
Publicat: (2017)

Evaluation of genetics of cancer predisposition in patients and efficacy of various chemotherapeutic drugs in Bangladesh
per: Hossain, Safa Binte
Publicat: (2019)

Potential of nanoparticles as a topical drug delivery system for skin cancer: a review
per: Islam, Karima
Publicat: (2022)

ক্যান্সার : মৃত্যু অবধারিত নয় /
per: করীম, আবুল বাশার মোহাম্মদ ফজলুল

Point-of care diagnostic devices in cancer detection
per: Yasmin, Rizwana
Publicat: (2022)